JP2019509344A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509344A5
JP2019509344A5 JP2019500035A JP2019500035A JP2019509344A5 JP 2019509344 A5 JP2019509344 A5 JP 2019509344A5 JP 2019500035 A JP2019500035 A JP 2019500035A JP 2019500035 A JP2019500035 A JP 2019500035A JP 2019509344 A5 JP2019509344 A5 JP 2019509344A5
Authority
JP
Japan
Prior art keywords
fatty acids
omega
lipid
triglyceride
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019500035A
Other languages
English (en)
Japanese (ja)
Other versions
JP6738477B2 (ja
JP2019509344A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/000548 external-priority patent/WO2017158439A1/en
Publication of JP2019509344A publication Critical patent/JP2019509344A/ja
Publication of JP2019509344A5 publication Critical patent/JP2019509344A5/ja
Application granted granted Critical
Publication of JP6738477B2 publication Critical patent/JP6738477B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019500035A 2016-03-16 2017-03-15 ω−3脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法 Active JP6738477B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662309013P 2016-03-16 2016-03-16
US62/309,013 2016-03-16
PCT/IB2017/000548 WO2017158439A1 (en) 2016-03-16 2017-03-15 Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production

Publications (3)

Publication Number Publication Date
JP2019509344A JP2019509344A (ja) 2019-04-04
JP2019509344A5 true JP2019509344A5 (https=) 2020-04-23
JP6738477B2 JP6738477B2 (ja) 2020-08-12

Family

ID=58994957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019500035A Active JP6738477B2 (ja) 2016-03-16 2017-03-15 ω−3脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法

Country Status (11)

Country Link
US (1) US20190364946A1 (https=)
EP (1) EP3429377B1 (https=)
JP (1) JP6738477B2 (https=)
KR (1) KR102263900B1 (https=)
CN (1) CN109068707B (https=)
AU (1) AU2017232554B2 (https=)
BR (1) BR112018068855A2 (https=)
CA (1) CA3017825C (https=)
CL (1) CL2018002656A1 (https=)
ES (1) ES2836729T3 (https=)
WO (1) WO2017158439A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
RS63725B1 (sr) 2020-05-18 2022-12-30 Orexo Ab Nova farmaceutska kompozicija za davanje leka
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
AR127780A1 (es) 2021-11-25 2024-02-28 Orexo Ab Nueva composición farmacéutica que comprende adrenalina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110009A1 (de) * 1981-03-11 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue benzofuran-derivate, ihre herstellung und verwendung
CN1140332C (zh) * 2001-10-24 2004-03-03 中国科学院新疆化学研究所 共轭亚油酸或共轭亚油酸酯的微胶囊
CN1152739C (zh) * 2001-10-26 2004-06-09 中国科学院新疆理化技术研究所 共轭亚油酸及其衍生物的环糊精包结的微胶囊
CN1295970C (zh) * 2005-07-08 2007-01-24 浙江大学 山茶油微胶囊的制备方法
EP1906745B1 (en) * 2005-07-22 2011-09-14 Unilever PLC Beverage precursor and process for manufacture thereof
WO2007041077A2 (en) * 2005-09-30 2007-04-12 Janssen Pharmaceutica N.V. Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
WO2008036353A2 (en) * 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
SG179497A1 (en) * 2007-03-29 2012-04-27 Daiichi Sankyo Co Ltd Pharmaceutical composition
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
WO2010119319A1 (en) * 2009-03-09 2010-10-21 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
CN101692853B (zh) * 2009-10-12 2012-05-30 华南农业大学 一种可食性粉末茶油及其制备方法
AU2010309517B2 (en) * 2009-10-23 2016-10-20 Pronova Biopharma Norge As Coated capsules and tablets of a fatty acid oil mixture
KR20130139896A (ko) * 2010-09-08 2013-12-23 프로노바 바이오파마 너지 에이에스 유리산 형태의 epa 및 dha, 계면활성제, 및 스타틴을 포함하는 조성물
US20120156296A1 (en) * 2010-12-21 2012-06-21 Omegatri As Antioxidants in fish oil powder and tablets
EP3072510B1 (en) * 2012-03-30 2019-05-08 Micelle BioPharma, Inc. Omega-3 fatty acid ester compositions
CN104244931A (zh) * 2012-04-27 2014-12-24 默克专利股份有限公司 经包衣的片剂及其制备
US10245273B2 (en) * 2013-12-26 2019-04-02 Clarus Therapeutics, Inc. Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
CN104920639B (zh) * 2015-07-03 2018-08-21 山东省农业科学院农产品研究所 一种牡丹籽油微胶囊的制备方法
CN106035752A (zh) * 2016-06-08 2016-10-26 华南理工大学 一种富含植物甾醇的多不饱和油脂粉末及其制备方法

Similar Documents

Publication Publication Date Title
JP2019509344A5 (https=)
JP2013508296A5 (https=)
HRP20200068T1 (hr) Etilni ester ikozapentaenske kiseline, namijenjen liječenju hipertrigliceridemije
JP2015527386A5 (https=)
JP2015520235A5 (https=)
JP2018184458A5 (https=)
TW201343203A (zh) 含有ω-3脂肪酸之經明膠/藻酸鹽延緩釋放型膠囊,其製法及用途
JP2009541433A (ja) オメガポリエン脂肪酸の経口投与のための医薬品の組成物、及び1又はそれ以上の配合禁忌の有効成分、並びにその調剤の工程
CN101816420A (zh) 一种微乳化多不饱和脂肪酸产品及制备方法
EP3062785A1 (en) Enteric soft capsules comprising polyunsaturated fatty acids
CA3072658C (en) Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
JP2011519349A5 (https=)
EP3648748A1 (en) Enteric coated solid dosage form comprising omega-3 fatty acid amino acid salts
RU2013133411A (ru) Новый препарат системы, высвобождающейся в кишечнике
JP2010531684A5 (https=)
CA2625554A1 (en) Enteric soft capsule comprising valproic acid
FI3664628T3 (fi) Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia
WO2013072767A1 (en) Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
RU2016115985A (ru) Лактоферрин для лечения ibd, вызванного бактериальной инвазией
CA3025425A1 (en) Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
JP4874651B2 (ja) 軟カプセル剤
JP2017516811A5 (https=)
JP5847475B2 (ja) 油脂含有組成物、及びそれを含む経口製剤
WO2008088808A1 (en) Treatment with non-steroidal anti-inflammatory drugs and omega-3 fatty acids, and a combination product thereof
US9314435B2 (en) Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules